Novel And Powerful Mhc-Class Ii Peptides Derived From Survivin And Neurocan

Patent No. EP2119726 (titled "Novel And Powerful Mhc-Class Ii Peptides Derived From Survivin And Neurocan") was filed by Immatics Biotechnologies on May 14, 2008. The application was issued on Nov 29, 2017.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CABINET ORESSep 24, 2015GEVERS & ORES

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2119726

IMMATICS BIOTECHNOLOGIES
Application Number
EP08008944A
Filing Date
May 14, 2008
Status
Patent Maintained As Amended
Oct 27, 2017
Publication Date
Nov 29, 2017